Thông tư 02/2016/TT-BYT

Circular No. 02/2016/TT-BYT dated January 12th, 2016, addition to Article 9 of the Circular No. 14/2012/TT-BYT on principles and criteria for “good manufacturing practice for pharmaceutical packaging" and guidelines for implementation

Nội dung toàn văn Circular 02/2016/TT-BYT addition Article 9 14/2012/TT-BYT good manufacturing pharmaceutical packaging


MINISTRY OF HEALTH
-------

SOCIALIST REPUBLIC OF VIETNAM
Independence – Freedom - Happiness
--------------

No. 02/2016/TT-BYT

Hanoi, January 12, 2016

 

CIRCULAR

ADDITION TO ARTICLE 9 OF THE CIRCULAR NO. 14/2012/TT-BYT DATED AUGUST 31, 2012 BY MINISTER OF HEALTH ON PRINCIPLES AND CRITERIA FOR “GOOD MANUFACTURING PRACTICE FOR PHARMACEUTICAL PACKAGING" AND GUIDELINES FOR IMPLEMENTATION

Pursuant to the Pharmacy Law No. 34/2005/QH11 dated June 14, 2005;

Pursuant to the Government’s Decree No. 63/2012/ND-CP dated August 31, 2012 on functions, missions, authority and organizational structure of the Ministry of Health;

At the requests of the Head of the Drug Administration of Vietnam and Head of the Department of Legal affairs - Ministry of Health.

Minister of Health issues the Circular on the following addition to Article 9 of the Circular No. 14/2012/TT-BYT dated August 31, 2012 by Minister of Health on principles and criteria for “Good manufacturing practice (GMP) for pharmaceutical packaging” and guidelines for implementation:

Article 1. Point d and Point dd are added to Section 5, Article 9 of the Circular No. 14/2012/TT-BYT dated August 31, 2012 by Minister of Health on principles and criteria for “Good manufacturing practice (GMP) for pharmaceutical packaging” and guidelines for implementation.

Article 9. Plan of implementation

5. Progress of implementation:

d) From the date that this Circular comes into force, manufacturers of drugs being sold in the market must use primary packaging, which are provided by packaging producers fulfilling GMP requirements for pharmaceutical packaging or possessing one of these certificates:

- Certificates of conformity of pharmaceutical packaging producer to GMP, as issued by competent health or pharmaceutical authorities.

- Certificates of eligibility for production of pharmaceutical packaging, as issued by competent health and pharmaceutical authorities in relevant countries, papers granted by pharmaceutical authorities in nations that participate in the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human use (ICH), European Union (EU), Pharmaceutical Inspection Co-operation Scheme (PIC/S) for endorsement of manufacturing of packaging for pharmaceutical products and foodstuffs, Drug Master File (DMF) recognized by U.S. Food and Drug Administration (USFDA) with the link to the information post on the website of USFDA.

- ISO 15378 certificate (Primary packaging materials for medicinal products - Particular requirements for application of ISO 9001:2008 with reference to Good Manufacturing Practices (GMP)) as issued by a certifying body that has been assessed and recognized by an international accreditation organization according to international standards.

- ISO 13485 certificate (Medical Devices - Quality management systems - Requirements for regulatory purposes) for packaging of drug containment tools (cartridge and syringe) as issued by a certifying body that has been assessed and recognized by an international accreditation organization according to international standards.

- ISO 9001 certificate (Quality management systems - Requirements) for materials of pharmaceutical packaging shaped right in the process of drug manufacturing.

dd) International accreditation organizations as stated in Point d of this Section include: Bureau Veritas, TÜV (Technischer Überwachungs Verein), SQS (Swiss Association for Quality and Management Systems), SGS (Société Générale de Surveillance), IQnet (The International Certification Network), BSI (The British Standards Institution), DQS (German Registration for Management Systems), GTÜ (Gesellschaft für Technische Überwachung), International Certification Management GmbH.

Article 2. Implementation

1. This Circular comes into force as of March 01, 2016.

2. Drug Administration of Vietnam shall cooperate with the Administration of Science Technology and Training to review and present information to the Minister of Health for issuance of circulars on amendments to or removal of international accreditation organizations as stated in Point dd, Section 5, Article 9 as supplemented by Article 1 of this Circular.

3. Certificates of GMP for pharmaceutical packaging, which were issued before the date that this Circular takes effect, shall remain effective to their date of expiry.

Difficulties shall be reported to the Drug Administration of Vietnam - Ministry of Health for solutions./.

 

 

FOR MINISTER
DEPUTY MINISTER





Pham Le Tuan

 


------------------------------------------------------------------------------------------------------
This translation is made by LawSoft and for reference purposes only. Its copyright is owned by LawSoft and protected under Clause 2, Article 14 of the Law on Intellectual Property.Your comments are always welcomed

Đã xem:

Đánh giá:  
 

Thuộc tính Văn bản pháp luật 02/2016/TT-BYT

Loại văn bảnThông tư
Số hiệu02/2016/TT-BYT
Cơ quan ban hành
Người ký
Ngày ban hành12/01/2016
Ngày hiệu lực01/03/2016
Ngày công báo...
Số công báo
Lĩnh vựcThể thao - Y tế
Tình trạng hiệu lựcCòn hiệu lực
Cập nhật9 năm trước
Yêu cầu cập nhật văn bản này

Download Văn bản pháp luật 02/2016/TT-BYT

Lược đồ Circular 02/2016/TT-BYT addition Article 9 14/2012/TT-BYT good manufacturing pharmaceutical packaging


Văn bản bị đính chính

    Văn bản được hướng dẫn

      Văn bản đính chính

        Văn bản bị thay thế

          Văn bản hiện thời

          Circular 02/2016/TT-BYT addition Article 9 14/2012/TT-BYT good manufacturing pharmaceutical packaging
          Loại văn bảnThông tư
          Số hiệu02/2016/TT-BYT
          Cơ quan ban hànhBộ Y tế
          Người kýPhạm Lê Tuấn
          Ngày ban hành12/01/2016
          Ngày hiệu lực01/03/2016
          Ngày công báo...
          Số công báo
          Lĩnh vựcThể thao - Y tế
          Tình trạng hiệu lựcCòn hiệu lực
          Cập nhật9 năm trước

          Văn bản thay thế

            Văn bản được dẫn chiếu

              Văn bản hướng dẫn

                Văn bản được hợp nhất

                  Văn bản hợp nhất

                    Văn bản gốc Circular 02/2016/TT-BYT addition Article 9 14/2012/TT-BYT good manufacturing pharmaceutical packaging

                    Lịch sử hiệu lực Circular 02/2016/TT-BYT addition Article 9 14/2012/TT-BYT good manufacturing pharmaceutical packaging

                    • 12/01/2016

                      Văn bản được ban hành

                      Trạng thái: Chưa có hiệu lực

                    • 01/03/2016

                      Văn bản có hiệu lực

                      Trạng thái: Có hiệu lực